Clinical trial
Development of a Novel Biomarker for Liver Fibrosis
NCT02348814 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Development of a Novel Biomarker for Liver Fibrosis
- Lead sponsor
- University of California, Los Angeles
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2015
- Completion date
- February 26, 2019
- Enrollment
- 25 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
liver fibrosis